Health Care

Nevro Corp (NYSE: NVRO) announced a series of board changes and the appointment of a new CEO after the close Tuesday.  The medical device company's stock was surging Wednesday on the news.  The changes at the helm and to the board come in the wake of pressure from Broadfin...

Altimmune Inc (NASDAQ: ALT), which develops immunotherapies and vaccines, is seeing its stock surge on 15 times its average volume after the company reported the results of a midstage study of its lead candidate NasoVAX. What Happened The nanocap biotech company said Tuesday that additional data...

Amarin Corporation (NASDAQ: AMRN) presented data for its cardiovascular outcome study of its prescription Vascepa (icosapent ethyl), the REDUCE-IT study. Vascepa demonstrated a statistically significant 30 percent risk reduction in cardiovascular events compared to placebo in the statin-treated...

Bausch Health Companies Inc’s (NYSE: BHC) growth drivers will become “more tangible” in 2019, and shares could appreciate as the company continues to demonstrate good execution, according to Mizuho Securities. The Analyst Mizuho’s Irina Koffler maintained a Buy rating...

Insys Therapeutics (NASDAQ: INSY) shares were crashing Wednesday after the company disclosed in its annual filing that the auditor's opinion on its audited financial statements include a paragraph stating concerns about the company's ability to continue. The stock was halted on a...

Bernstein is bullish on the prospects for CVS Health Corp (NYSE: CVS), notwithstanding the headwinds facing pharmacy benefit managers, or PBMs, given the likelihood that the bulk of prescriptions may ultimately move online. The Analyst Analyst Lance Wilkes initiated coverage of CVS Health with an...

Eli Lilly And Co (NYSE: LLY) is the best-positioned among large caps, given healthy core product growth, a growing portfolio of new launches and next-gen pipeline assets, potential for significant margin expansion and several sources of near- and long-term upside, according to JPMorgan. The Analyst...

The first specialized medical cannabis clinic in the United Kingdom opened in Manchester on Saturday. It's a major step for the country that in November rescheduled certain cannabis products allowing medical professionals to prescribe them. What Happened The new Medical Cannabis Clinic will be...

Meetings with Stryker Corporation’s (NYSE: SYK) CEO inspired greater confidence in the company’s topline growth being sustainable into the foreseeable future, as well as near- and medium-term cost-saving opportunities, according to RBC Capital Markets. The Analyst RBC Capital Markets...

Smaller gene therapy biotechs are taking the spotlight given the M&A interest surrounding them. One such gene therapy company saw its shares rallying by more than 30 percent Monday following the release of clinical trial results for two of its gene therapies. What Happened...

With diabetes rates for truckers running 50 percent higher than the national average, industry and health advocacy groups are working to raise awareness about how drivers can manage the disease and ensure a high level of public safety. About 15 percent – or 500,000 truckers in the United...

Whenever pot is discussed, two acronyms — tetrahydrocannabinol, or THC, and cannabidiol, or CBD — are usually mentioned in the same breath. The following is a look at how the substances differ. The Science Cannabis sativa, an annual herbaceous flowering plant, has numerous uses thanks...

Allergan plc (NYSE: AGN) was in for a disappointment with its investigational depression drug candidate Rapastinel, one day after Johnson & Johnson (NYSE: JNJ) secured FDA approval for its treatment-resistant depression drug esketamine. The Analysts Wells Fargo Securities analyst David Maris...

More than three decades after the launch of Eli Lilly And Co (NYSE: LLY)'s Prozac, a major new depression drug has been approved with a faster mode of action than existing treatments.  What Happened Johnson & Johnson (NYSE: JNJ)'s Janssen unit announced Tuesday that the FDA...

U.S. Food and Drug Commissioner Scott Gottlieb is resigning, The Washington Post reported Tuesday afternoon. Gottlieb, a physician, former banker and venture capitalist, had made youth vaping his focal issue on the FDA. A former advisor to pharmaceutical companies, Gottlieb was initially criticized...